Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods

Details for Australian Patent Application No. 2002319677 (hide)

International Classifications

Event Publications

16 January 2003 Complete Application Filed

Priority application(s): 60/307,439 23.07.01 US; 60/353,702 31.01.02 US

29 May 2003 Application Open to Public Inspection

Published as AU-B-2002319677

22 April 2004 Amendment Made

The nature of the amendment is: Add the co-inventors Boddupalli, Sekhar, Gilat, Sylvian and Bobzin, Steven

22 April 2004 Change of Name(s) of Applicant(s), Section 104

Galileo Laboratories, Inc. The name of the applicant has been changed to Galileo Pharmaceuticals, Inc.

13 May 2004 Corrigenda

Amendments, Section 104 - Amendments Made Under the name Galileo Pharmaceuticals, Inc. Application No. 2002319677, under INID (72) correct the inventor to read Gilat, Sylvain

30 November 2006 Assignment before Grant

Galileo Pharmaceticals Inc The application has been assigned to Johnson & Johnson Consumer Companies, Inc

26 March 2009 Application Accepted

Published as AU-B-2002319677

30 April 2009 Corrigenda

Applications Accepted - Name Index Under the name Johnson & Johnson Consumer Companies, Inc, Application No. 2002319677, under INID(72), correct the co-inventors name to Chen, Jian and Del Balzo, Ughetta

23 July 2009 Standard Patent Sealed

24 June 2010 Assignment Registered

Johnson & Johnson Consumer Companies, Inc The patent has been assigned to Atwater Management LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.